In Depth 7 May 2025 Unlocking immunity: the power of TLR agonists Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial. May 7, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Apr 2025 Top biotech deals of March 2025 Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations. April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Apr 2025 Beyond amyloid: The search for the next big thing in Alzheimer’s treatment Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments. April 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 26 Mar 2025 A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations. March 26, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2025 First-ever RIPTAC enters clinic: all you need to know about this new cancer approach The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics. March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2025 DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs. February 13, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 22 Nov 2024 Can AlphaFold3’s open-source platform revolutionize the way we discover drugs? Find out how Google DeepMind’s AlphaFold3 platform could help scientists revolutionize the field of drug discovery. November 22, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2024 Booster launches to treat neurodegenerative diseases with proteasome activation Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million. October 15, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 27 Sep 2024Harnessing the body’s natural targeted protein degradation system to treat diseases Listen to our conversation with Andrew Hirsch, CEO at C4 Therapeutics, a leader in the targeted protein degradation field. September 27, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Lonza 3 Sep 2024 The crucial role of GS-CHO innovation in biopharmaceutical progress Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins. September 3, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by KBI Biopharma 16 Jul 2024 How a microbial expression update is driving biotech innovation Discover how microbial expression systems are revolutionizing protein production for next-gen therapies like antibodies and peptides. July 16, 2024 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 26 Mar 2024 Large molecule manufacturing: addressing challenges with strategies for success Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success. March 26, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email